The wait is over: learn more about Tessie and Bonqat

Tessie is the first fast-acting dual-purpose solution for separation and noise-related problems for dogs. Bonqat is the first licensed feline anxiolytic, for acute fear and anxiety associated with transportation and veterinary visits.

In the UK, situational anxiety in pets is a growing problem, with 1.4 million¹ dogs showing signs of distress when left alone, and 4 million dogs¹ showing fear of loud noises. In addition, more than 4 million cats² are not having routine vet checkups, with 26%² of these owners reporting that it is too stressful for their cat or themselves.

Both Tessie® and Bonqat® provide vets with NEW fast-acting treatments, to be considered alongside other management options for pet anxiety cases.

References

1. PDSA Paw Report 2023 – https://www.pdsa.org.uk/media/13976/pdsa-paw-report-2023.pdf (accessed 16 October 2024).

2. Cats Report 2024 – https://www.cats.org.uk/media/hzfjahh2/cats-report-uk-2024.pdf (accessed 16 October 2024).

• BONQAT 50MG/ML ORAL SOLUTION FOR CATS. Contains Pregabalin. POM-V. Schedule III. TESSIE 0.3 MG/ML ORAL SOLUTION FOR DOGS. Contains Tasipimidine. POM-V. This document is intended for GB distribution only. ©2024 Orion Group. All rights reserved. For further information and to view the full Summary of Product Characteristics, please contact TVM UK Animal Health Ltd. www.domespharma.co.uk  Dômes Pharma is the trading name of TVM UK Animal Health Ltd
• Use Medicines Responsibly. www.noah.co.uk/responsible – Prescription decisions are for the person issuing the prescription alone.